Superstring Capital Management key facts
- Superstring Capital Management is a hedge fund based in New York, New York with 3 tracked portfolio companies.
- Notable positions include Caidya, ReCode Therapeutics, Trinomab(Zhuhai).
- Superstring Capital Management reports $181.0M in regulatory assets under management across 2 private funds, per its SEC Form ADV (2026-03).
About Superstring Capital Management
249920-20P
Investment focus
Its SEC Form ADV lists $181 million in regulatory assets under management across 2 private funds (Mar 2026).
Superstring Capital Management portfolio at a glance
3 portfolio companies are on record for Superstring Capital Management: Caidya, ReCode Therapeutics and Trinomab(Zhuhai).
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
Superstring Capital Management at the SEC
Form ADV · 2026-03 · CRD 305743- Regulatory AUM
- $181.0M
- Private fund assets
- $315.7M
- Private funds
- 2 · 1 private equity, 1 hedge
- Staff
- 5
- Registered office
- NEW YORK, NY
- SEC status
- Approved
Reports custody of client assets.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as SUPERSTRING CAPITAL MANAGEMENT LP).
Free account
See more of the book
- ·Watchlist + alerts for Superstring Capital Management's activity
Portfolio
3 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Caidya | Other Healthcare Services | ▮ | ▮ | ▮ |
| ReCode Therapeutics | — | ▮ | ▮ | ▮ |
| Trinomab(Zhuhai) | — | ▮ | ▮ | ▮ |
All 3 companies — valuations, dates and lead flags are a member feature Membership and data by Private Market View | ||||
Frequently asked about Superstring Capital Management
- What companies does Superstring Capital Management invest in?
- Superstring Capital Management has 3 recorded portfolio companies, including Caidya, ReCode Therapeutics, Trinomab(Zhuhai).
- What is Superstring Capital Management's AUM?
- Superstring Capital Management manages approximately $181.0M in assets.